Medpace Voice

I was interested in expanding my horizons beyond basic research and developing my knowledge in applied flow cytometry research. I...

Authors: Carmen Gasca-Salas, MD, MSc, PhD, Medical Director, Medpace  Recently, the Medpace neuroscience team attended the AD/PD (Alzheimer’s & Parkinson’s Disease)...

As a Hematologist/Oncologist, I have always been a life-long advocate of the rigor and structure of a clinical trial. That...

I joined Medpace in 2006. I’ve had the privilege of experiencing Medpace’s labs from its early stages through its global...

In this newly published episode of Seamless Insights: The Podcast, Hamish Baird, President of Remington Davis, sits down with Medpace...

Authors: James Vornov MD, PhD and Jessica Yehnert Recently, the Medpace stroke team attended ISC (International Stroke Conference). Among the many presentations, one study in...

March 4th marks World Obesity Day, a unified day of action that calls for a cohesive, cross-sector response to the...

Santica Marcovina, PhD, ScD, FAHA, shares how advanced biomarker science is shaping today’s lipid-focused trials.

Rare disease clinical development is undergoing rapid transformation, driven by scientific innovation, evolving regulatory frameworks, and the need for more flexible, patient-centric trial designs.

Medpace is proud to welcome Dr. Sonia Quintas, an accomplished and board-certified Neurologist, to our medical leadership team.  Dr. Quintas brings nearly a decade of...